Back to Search Start Over

OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial

Authors :
Franco Mascayano
Iruma Bello
Howard Andrews
Diego Arancibia
Tamara Arratia
María Soledad Burrone
Sarah Conover
Kim Fader
Maria Jose Jorquera
Mauricio Gomez
Sergio Malverde
Gonzalo Martínez-Alés
Jorge Ramírez
Gabriel Reginatto
Alexandra Restrepo-Henao
Robert A. Rosencheck
Sara Schilling
Thomas E. Smith
Gonzalo Soto-Brandt
Eric Tapia
Tamara Tapia
Paola Velasco
Melanie M. Wall
Lawrence H. Yang
Leopoldo J. Cabassa
Ezra Susser
Lisa Dixon
Rubén Alvarado
Source :
Trials, Vol 23, Iss 1, Pp 1-17 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Background Substantial data from high-income countries support early interventions in the form of evidence-based Coordinated Specialty Care (CSC) for people experiencing First Episode Psychosis (FEP) to ameliorate symptoms and minimize disability. Chile is unique among Latin American countries in providing universal access to FEP services through a national FEP policy that mandates the identification of FEP individuals in primary care and guarantees delivery of community-based FEP treatments within a public health care system. Nonetheless, previous research has documented that FEP services currently provided at mental health clinics do not provide evidence-based approaches. This proposal aims to address this shortfall by first adapting OnTrackNY (OTNY), a CSC program currently being implemented across the USA, into OnTrackChile (OTCH), and then examine its effectiveness and implementation in Chile. Methods The Dynamic Adaptation Process will be used first to inform the adaptation and implementation of OTCH to the Chilean context. Then, a Hybrid Type 1 trial design will test its effectiveness and cost and evaluate its implementation using a cluster-randomized controlled trial (RCT) (N = 300 from 21 outpatient clinics). The OTCH program will be offered in half of these outpatient clinics to individuals ages 15-35. Usual care services will continue to be offered at the other clinics. Given the current COVID-19 pandemic, most research and intervention procedures will be conducted remotely. The study will engage participants over the course of 2 years, with assessments administered at enrollment, 12 months, and 24 months. Primary outcomes include implementation (fidelity, acceptability, and uptake) and service outcomes (person-centeredness, adherence, and retention). Secondary outcomes comprise participant-level outcomes such as symptoms, functioning, and recovery orientation. Over the course of the study, interviews and focus groups with stakeholders will be conducted to better understand the implementation of OTCH. Discussion Findings from this study will help determine the feasibility, effectiveness, and cost for delivering CSC services in Chile. Lessons learned about facilitators and barriers related to the implementation of the model could help inform the approach needed for these services to be further expanded throughout Latin America. Trial registration www.ClinicalTrials.gov NCT04247711 . Registered 30 January 2020. Trial status The OTCH trial is currently recruiting participants. Recruitment started on March 1, 2021, and is expected to be completed by December 1, 2022. This is the first version of this protocol (5/12/2021).

Details

Language :
English
ISSN :
17456215
Volume :
23
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Trials
Publication Type :
Academic Journal
Accession number :
edsdoj.8b814ea4e9a4cba8f5e7a9ee8ca84a1
Document Type :
article
Full Text :
https://doi.org/10.1186/s13063-022-06661-7